Annual Retained Earnings
-$375.28 M
-$25.43 M-7.27%
December 31, 2022
Summary
- As of February 10, 2025, CYAD annual retained earnings is -$375.28 million, with the most recent change of -$25.43 million (-7.27%) on December 31, 2022.
- During the last 3 years, CYAD annual retained earnings has fallen by -$291.92 million (-350.16%).
Performance
CYAD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$337.46 M
+$15.87 M+4.49%
June 30, 2022
Summary
- As of February 10, 2025, CYAD quarterly retained earnings is -$337.46 million, with the most recent change of +$15.87 million (+4.49%) on June 30, 2022.
- Over the past year, CYAD quarterly retained earnings has dropped by -$262.09 million (-347.76%).
Performance
CYAD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CYAD Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | -347.8% |
| 3 y3 years | -350.2% | -382.9% |
| 5 y5 years | -73.4% | -113.1% |
CYAD Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +7.3% | at low | at high | +4.7% |
| 5 y | 5-year | +350.2% | at low | +347.8% | +4.7% |
| alltime | all time | +3071.8% | at low | +935.3% | +4.7% |
Celyad Oncology SA Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$375.28 M(+7.3%) | - |
| Jun 2022 | - | -$337.46 M(-4.5%) |
| Mar 2022 | - | -$353.33 M(+1.0%) |
| Dec 2021 | -$349.85 M(+0.5%) | -$349.85 M(+326.5%) |
| Sep 2021 | - | -$82.03 M(+8.8%) |
| Jun 2021 | - | -$75.37 M(-36.0%) |
| Mar 2021 | - | -$117.85 M(-66.1%) |
| Dec 2020 | -$348.13 M(+317.6%) | -$348.13 M(+240.1%) |
| Jun 2020 | - | -$102.37 M(+22.8%) |
| Dec 2019 | -$83.37 M(-66.5%) | -$83.37 M(+19.3%) |
| Jun 2019 | - | -$69.88 M(-72.0%) |
| Dec 2018 | -$249.12 M | -$249.12 M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$229.95 M(+6.2%) |
| Dec 2017 | -$216.45 M(+65.1%) | -$216.45 M(+36.7%) |
| Jun 2017 | - | -$158.37 M(+20.8%) |
| Dec 2016 | -$131.12 M(+19.6%) | -$131.12 M(+0.5%) |
| Jun 2016 | - | -$130.41 M(+18.9%) |
| Dec 2015 | -$109.67 M(+26.6%) | -$109.67 M(+13.7%) |
| Jun 2015 | - | -$96.45 M(+11.4%) |
| Dec 2014 | -$86.60 M(+72.3%) | -$86.60 M(+50.1%) |
| Jun 2014 | - | -$57.69 M(+14.8%) |
| Dec 2013 | -$50.25 M(+54.2%) | -$50.25 M(+26.5%) |
| Jun 2013 | - | -$39.71 M(+21.8%) |
| Dec 2012 | -$32.60 M(+175.5%) | -$32.60 M |
| Dec 2011 | -$11.83 M | - |
FAQ
- What is Celyad Oncology SA annual retained earnings?
- What is the all time high annual retained earnings for Celyad Oncology SA?
- What is Celyad Oncology SA annual retained earnings year-on-year change?
- What is Celyad Oncology SA quarterly retained earnings?
- What is the all time high quarterly retained earnings for Celyad Oncology SA?
- What is Celyad Oncology SA quarterly retained earnings year-on-year change?
What is Celyad Oncology SA annual retained earnings?
The current annual retained earnings of CYAD is -$375.28 M
What is the all time high annual retained earnings for Celyad Oncology SA?
Celyad Oncology SA all-time high annual retained earnings is -$11.83 M
What is Celyad Oncology SA annual retained earnings year-on-year change?
Over the past year, CYAD annual retained earnings has changed by -$25.43 M (-7.27%)
What is Celyad Oncology SA quarterly retained earnings?
The current quarterly retained earnings of CYAD is -$337.46 M
What is the all time high quarterly retained earnings for Celyad Oncology SA?
Celyad Oncology SA all-time high quarterly retained earnings is -$32.60 M
What is Celyad Oncology SA quarterly retained earnings year-on-year change?
Over the past year, CYAD quarterly retained earnings has changed by -$262.09 M (-347.76%)